ID   X50-7
AC   CVCL_8277
DR   Wikidata; Q54994648
RX   Patent=US5178999;
RX   PubMed=218224;
RX   PubMed=223286;
RX   PubMed=3033285;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
RX   Patent=US5178999;
RA   Miller G., Dahl K.E.;
RT   "Epstein-Barr virus transformed cell lines superinfected with a second
RT   virus.";
RL   Patent number US5178999, 12-Jan-1993.
//
RX   PubMed=218224; DOI=10.1073/pnas.76.2.949;
RA   Miller G., Wertheim-van Dillen P.M.E., Wilson G., Robinson J.,
RA   Geelen J.L.M.C., van der Noordaa J., van der Eb A.J.;
RT   "Transfection of human lymphoblastoid cells with herpes simplex viral
RT   DNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 76:949-953(1979).
//
RX   PubMed=223286; DOI=10.1016/0042-6822(79)90490-2;
RA   Wilson G., Miller G.;
RT   "Recovery of Epstein-Barr virus from nonproducer neonatal human
RT   lymphoid cell transformants.";
RL   Virology 95:351-358(1979).
//
RX   PubMed=3033285; DOI=10.1128/JVI.61.5.1602-1608.1987;
RA   Dahl K.E., Martin K., Miller G.;
RT   "Differences among human immunodeficiency virus strains in their
RT   capacities to induce cytolysis or persistent infection of a
RT   lymphoblastoid cell line immortalized by Epstein-Barr virus.";
RL   J. Virol. 61:1602-1608(1987).
//